A Partisan Tale: The FTC's Vertical Merger Enforcement Commentary
Client Alert | 2 min read | 01.06.21
In a hotly contested 3-to-2 vote, the Federal Trade Commission in December 2020 issued a 43-page Commentary on Vertical Merger Enforcement (“Commentary”) that examines the agency’s prior vertical merger enforcement actions. While the Commentary does not break new ground, it helpfully compiles the FTC’s vertical enforcement record from the past quarter century and summarizes the Commission’s theories of harm and analysis of both anticompetitive effects (e.g., foreclosure and raising rivals’ costs) and pro-competitive benefits (e.g., elimination of double marginalization and efficiencies) in vertical merger reviews. Most notably, the Commissioners’ statements on the Commentary once again reveal a deep split—along party lines—about the agency’s approach to vertical merger enforcement and remedies, and portend potentially substantial enforcement changes under the Biden administration.
In addition to voting with Chairman Simons to issue the Commentary, Commissioners Phillips and Wilson explained in a concurring statement that the Commentary is intended to promote transparency and facilitate both the predictability and credibility of the Commission’s vertical merger review process.
By contrast, as they did when the revised Vertical Merger Guidelines were released in June 2020, Commissioners Chopra and Slaughter opposed issuing the Commentary and issued a vigorous dissenting statement. They described the Commentary as “flawed” because it supports “the same status quo thinking that has allowed decades of vertical consolidation to go uninvestigated and unchallenged,” and because it highlights the agency’s use of behavioral remedies, the efficacy of which, they say, “is suspect.”
The last paragraph of the dissenting statement warns:
We strongly caution the market against relying on the Vertical Merger Guidelines and the Vertical Merger Commentary as an indication of how the FTC will act upon past, present, and future transactions. Moving forward, we need to aggressively enforce against the harms of vertical mergers. We look forward to turning the page on the era of lax oversight and to beginning to investigate, analyze, and enforce the antitrust laws against vertical mergers with vigor.
Commissioners Phillips and Wilson criticized the dissenting Commissioners in their concurring statement, noting that “[a]ny proposals for a new approach to vertical merger enforcement, which our colleagues have yet to articulate, would need to take into account and grapple with the law, economics, and the evidence in each case. Until then, vague promises of a dramatic and undefined change in enforcement ring hollow.”
Although the FTC has not been traditionally considered a partisan agency, the Commissioners’ statements reveal fundamental and recurring party-line disagreements on approaches to vertical merger enforcement and remedies, exhibited in several instances since 2017 (e.g., the Staples/Essendant consent, the Fresenius/NxStage consent, and draft and final Vertical Merger Guidelines). Under the incoming Biden administration, vertical merger enforcement and remedies may change significantly if a third Commissioner shares the views of Commissioners Chopra and Slaughter.
Contacts
Insights
Client Alert | 5 min read | 12.12.25
Eleventh Circuit Hears Argument on False Claims Act Qui Tam Constitutionality
On the morning of December 12, 2025, the Eleventh Circuit heard argument in United States ex rel. Zafirov v. Florida Medical Associates, LLC, et al., No. 24-13581 (11th Cir. 2025). This case concerns the constitutionality of the False Claims Act (FCA) qui tam provisions and a groundbreaking September 2024 opinion in which the United States District Court for the Middle District of Florida held that the FCA’s qui tam provisions were unconstitutional under Article II. See United States ex rel. Zafirov v. Fla. Med. Assocs., LLC, 751 F. Supp. 3d 1293 (M.D. Fla. 2024). That decision, penned by District Judge Kathryn Kimball Mizelle, was the first success story for a legal theory that has been gaining steam ever since Justices Thomas, Barrett, and Kavanaugh indicated they would be willing to consider arguments about the constitutionality of the qui tam provisions in U.S. ex rel. Polansky v. Exec. Health Res., 599 U.S. 419 (2023). In her opinion, Judge Mizelle held (1) qui tam relators are officers of the U.S. who must be appointed under the Appointments Clause; and (2) historical practice treating qui tam and similar relators as less than “officers” for constitutional purposes was not enough to save the qui tam provisions from the fundamental Article II infirmity the court identified. That ruling was appealed and, after full briefing, including by the government and a bevy of amici, the litigants stepped up to the plate this morning for oral argument.
Client Alert | 8 min read | 12.11.25
Director Squires Revamps the Workings of the U.S. Patent Office
Client Alert | 8 min read | 12.10.25
Creativity You Can Use: CJEU Clarifies Copyright for Applied Art
Client Alert | 4 min read | 12.10.25
Federal Court Strikes Down Interior Order Suspending Wind Energy Development


